Calloway Nathaniel 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Calloway Nathaniel
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-02-01−3,981→ 0 totalFrom: 2024-02-01→ Common Stock (3,981 underlying) - Exercise/Conversion
Common Stock
2024-02-01+3,981→ 28,069 total
Footnotes (2)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]The restricted stock units vested on February 1, 2024.